Project Grant R21TW013153
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $344K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- This $131,278 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training program) will support the University of Global Health Equity (UGHE) in Rwanda to research and implement decentralized breast biopsy services at district hospitals. The goal is to improve early diagnosis and treatment of breast cancer, a leading cause of cancer mortality in low- and middle-income countries like Rwanda. The 5-year project will build UGHE's capacity in...
- This Project Grant award of $1,553,810 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to evaluate a genomic surveillance approach for monitoring artemisinin resistance in Plasmodium falciparum malaria in Africa. The project aims to identify genetic mutations and altered biological functions associated with artemisinin resistance, which is a critical concern as resistance emerges...
- This Project Grant award, provided by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to investigate the impact of forced migration on HIV vulnerability and prevention among internally displaced adolescent girls and young women (AGYW) in Northern Mozambique. The funded project has two primary objectives: 1) to determine predictors of HIV vulnerability for this population, examining the relationship between exposure to...
- This $118,488 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) on January 20, 2025, supports research to develop HIV-resistant hematopoietic stem cells through targeted base editing. The project aims to identify genetic mutations in the CCR5 and CXCR4 co-receptors that can prevent HIV entry into CD4 cells while maintaining the central functions of these proteins in hematopoiesis. The research involves...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will provide up to $176,738 to Boston University Medical Campus over a 5-year period from September 1, 2025 to August 31, 2030. The grant will support research to optimize COVID-19 vaccination strategies in Malawi, a sub-Saharan African country, with a focus on assessing the longevity of antibody responses, the role of innate immunity, and the...
- The Fogarty International Center (FIC) of the National Institutes of Health awarded a $100,720 Project Grant under the International Research and Research Training program (CFDA 93.989) to The Infectious Diseases Institute Limited (IDI) in Uganda. The grant, titled "HIGH-PERFORMANCE COMPUTING FOR HIV RESEARCH EXCELLENCE (HPC4HIV)", aims to strengthen IDI's capacity to support Ugandan biomedical research, particularly HIV research, by training four local staff in high-performance...
- The U.S. Department of Health and Human Services' Fogarty International Center awarded a $215,902 Project Grant under the International Research and Research Training program (CFDA 93.989) to The Johns Hopkins University. The grant will fund the adaptation and pilot testing of a multi-level intervention package to improve antiretroviral therapy adherence and viral suppression among women living with HIV in Blantyre, Malawi. The intervention aims to address HIV-related stigma across...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the Fred Hutchinson Cancer Center in Seattle, WA will support research to understand the pathogenesis of classic Hodgkin lymphoma in persons living with HIV (PLWH). The $176,000 award will fund a 2-year study to identify persistent transcriptomic changes in immune cells from benign lymph nodes of PLWH on combination antiretroviral therapy, and compare these findings to changes in classic...
- The Fogarty International Center (FIC), part of the U.S. Department of Health and Human Services' National Institutes of Health, has awarded a $169,015 Project Grant (CFDA 93.989) to Kenyatta National Hospital in Kenya. The goal of this 5-year grant, awarded on September 16, 2025, is to develop and evaluate a urine dipstick-guided counseling intervention to support adherence and completion of the 3-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy regimen among people with...